Vaxil Bio Market Cap

Vaxil Bio has a market cap or net worth of CAD 1.16 million as of April 29, 2026. Its market cap has decreased by -57.83% in one year.

Market Cap

1.16M

Enterprise Value

708.37K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.29

Market Cap Chart

Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 1.16M, an increase of 1,086.73%. That is a compound annual growth rate of 27.67%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2026	1.16M	100.00%
Dec 30, 2025	577.68K	-83.13%
Dec 29, 2023	3.42M	25.00%
Dec 30, 2022	2.74M	-73.33%
Dec 31, 2021	10.27M	-70.43%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Entheon Biomedical	1.39M
Universal Ibogaine	1.56M
Rakovina Therapeutics	2.33M
Waverley Pharma	540.00K
BioVaxys Technology	2.65M
Appili Therapeutics	2.65M
ChitogenX	415.65K
ASEP Medical Holdings	3.45M

Market Cap Rankings